InspireMD Statistics
Share Statistics
InspireMD has 26.08M shares outstanding. The number of shares has increased by 11.2% in one year.
| Shares Outstanding | 26.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.47% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 19.48M |
| Failed to Deliver (FTD) Shares | 2.21K |
| FTD / Avg. Volume | 4.58% |
Short Selling Information
The latest short interest is 173.65K, so 0.67% of the outstanding shares have been sold short.
| Short Interest | 173.65K |
| Short % of Shares Out | 0.67% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 2.08 |
Valuation Ratios
The PE ratio is -3.42 and the forward PE ratio is -3.36.
| PE Ratio | -3.42 |
| Forward PE | -3.36 |
| PS Ratio | 10.99 |
| Forward PS | 2.6 |
| PB Ratio | 1.73 |
| P/FCF Ratio | -4.07 |
| PEG Ratio | n/a |
Enterprise Valuation
InspireMD Inc. has an Enterprise Value (EV) of 60.15M.
| EV / Earnings | -3.02 |
| EV / Sales | 9.69 |
| EV / EBITDA | -2.88 |
| EV / EBIT | -2.84 |
| EV / FCF | -3.59 |
Financial Position
The company has a current ratio of 7.34, with a Debt / Equity ratio of 0.
| Current Ratio | 7.34 |
| Quick Ratio | 6.99 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.5% and return on capital (ROIC) is -51.62%.
| Return on Equity (ROE) | -0.5% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | -51.62% |
| Revenue Per Employee | 95.46K |
| Profits Per Employee | -306.40K |
| Employee Count | 65 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.09 |
Taxes
| Income Tax | 65.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -12.75% in the last 52 weeks. The beta is 0.93, so InspireMD 's price volatility has been higher than the market average.
| Beta | 0.93 |
| 52-Week Price Change | -12.75% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 42.72 |
| Average Volume (20 Days) | 48.19K |
Income Statement
In the last 12 months, InspireMD had revenue of 6.21M and earned -19.92M in profits. Earnings per share was -0.82.
| Revenue | 6.21M |
| Gross Profit | 1.81M |
| Operating Income | -21.14M |
| Net Income | -19.92M |
| EBITDA | -20.91M |
| EBIT | -21.14M |
| Earnings Per Share (EPS) | -0.82 |
Balance Sheet
The company has 9.64M in cash and 1.59M in debt, giving a net cash position of 8.04M.
| Cash & Cash Equivalents | 9.64M |
| Total Debt | 1.59M |
| Net Cash | 8.04M |
| Retained Earnings | -221.50M |
| Total Assets | 50.48M |
| Working Capital | 39.13M |
Cash Flow
In the last 12 months, operating cash flow was -16.38M and capital expenditures -381.00K, giving a free cash flow of -16.76M.
| Operating Cash Flow | -16.38M |
| Capital Expenditures | -381.00K |
| Free Cash Flow | -16.76M |
| FCF Per Share | -0.69 |
Margins
Gross margin is 29.12%, with operating and profit margins of -340.74% and -320.97%.
| Gross Margin | 29.12% |
| Operating Margin | -340.74% |
| Pretax Margin | -319.92% |
| Profit Margin | -320.97% |
| EBITDA Margin | -337% |
| EBIT Margin | -340.74% |
| FCF Margin | -270.06% |
Dividends & Yields
NSPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -30.71% |
| FCF Yield | -24.06% |
Analyst Forecast
The average price target for NSPR is $4.75, which is 77.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.75 |
| Price Target Difference | 77.9% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Apr 27, 2021. It was a backward split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -2.92 |
| Piotroski F-Score | 1 |